| abstract |
The present disclosure is directed to imidodicarbonimidic diamide compounds, and their pharmaceutically acceptable salts, solvates, or stereoisomers thereof. This disclosure also provides compositions and the use of such compositions in method of treating cancer, diabetes, or polycystic ovarian syndrome. |